“showed a trend”

The analysis of 3-month mRS 0–2 found that history of smoking showed a trend for association with the meta-analysis ( P =0.061), but the meta-regression model was not significant (F 7,4 =2.58, P =0.189).

When compared with non-vitamin D and non-multivitamin users (n=1576), the vitamin D supplement users showed a trend towards accelerated global cognitive decline (difference: −0.044 points/year; 95% CI −0.091 to 0.002, p = 0.061), though this trend is not statistically significant ( online supplemental table S5 ).

The number of proinflammatory monocytes that decreased after probiotic supplementation also showed a trend to return to baseline after discontinuation of probiotic supplementation (p = 0.061) ( Fig. 6B ).

Ultimate failure load was greatest in the DR group at 305 N ±12 and showed a trend toward higher ultimate failure load compared to the SRT group (170 N ±42; P = .061).

The effects of therapy on hand function Manual therapy led to improvements in females ( p < 0.001), while both the male and female control groups showed a trend toward a significant difference (male: p = 0.061; female: p = 0.083).

Senescent cell-injected left knees showed a trend to increased paw withdrawal ( p = .061) when using 0.16g monofilaments ( Figure 2D ).

CD showed a trend towards slower performance on interference trials ( p = 0.061, η 2 = 0.037) and was associated with significantly more errors on the Stroop Word-Reading ( p = 0.028, η 2 = 0.050) and Interference trials ( p = 0.046, η 2 = 0.041), suggestive of difficulties with inhibitory control and written language processing.

Maternal height showed a trend toward negative correlation with Jagged-1 ( r = -0.228, p = 0.061).

Postoperative biologics showed a trend toward improved outcomes compared to immunomodulators (77.3% vs 54.5%, HR = 2.624, 95% CI: 0.955–7.214, P = 0.061).

Planned LSmeans comparisons indicated that total prevalence was significantly higher in the 0.5 mg l -1 treatment than in controls ( P = 0.011), and showed a trend toward being higher in the 1.5 mg l -1 treatment than in controls ( P = 0.061).

Results of logistic regression showed a trend toward decreased local control probability with every single unitary increase in PTV_SIP absolute volume (OR 1.024, CI 0.99–1.05, p = 0.061), where 1.024 is the estimated local control odds ratio associated with a 1 cc increase in PTV_SIP absolute volume.

Direct comparison of VTA neurones between depressed and non-depressed DLB donors showed a trend towards higher VTA neurone counts in non-depressed DLB donors ( p = 0.061, Mann-Whitney U).

A log‐rank analysis showed a trend for higher relapse‐free probability in patients who received a minimum of 12 weeks of antifungal therapy ( p = 0.061) (Fig. 5 ).

In the second model with log‐transformed 24h‐UAE, the association with PWV showed a trend (st. β = 0.19, p = 0.061), while age ( p = 0.004) and HbA1c ( p = 0.002), but not sex, were significant predictors.

21.2%, p = 0.020) and showed a trend towards a higher risk of recurrence at the clivus (42.1% vs. 18.2%, p = 0.061), lateral pterygoid muscle (21.1% vs. 3.0%, p = 0.054), and hypoglossal canal (21.1% vs. 3.0%, p = 0.054).

The M parameter showed a trend towards a significant correlation with OS, although patients staged as M1 survived longer than those staged as M0 ( P =0.061; Fig. 3C ).

PERMANOVA showed a trend ( F = 3.51, p = 0.061), but ANCOM‐BC2 found no differentially abundant taxa.

Statistical analysis showed a trend for younger patients to develop less frequently postoperative neurological deficits ( F value = 1.627, P value = 0.0611).

Paired-sample t tests revealed that parameters α, β, and γ had significantly smaller recovery errors when stimulus constraints were used ( p < 10 −10 ), while σ only showed a trend effect ( p = 0.0615), but absolute recovery errors were significantly smaller for σ and γ ( p = 0.0071, p = 9.6457 × 10 −8 ) but not α and β ( p = 0.4405, p = 0.0610).

In a phase Ib/II randomized trial, the addition of olaratumab to doxorubicin failed to improve the primary endpoint of PFS compared with doxorubicin alone, but showed a trend toward improvement (6.6 vs. 4.1 months, p = .0615).

Compared to controls, patients showed a trend towards reduced LVMi at baseline (51.4 vs . 60.0 g/m 2 , p = 0.0615); this difference was lost by 1 year of GH treatment (57.3 vs. 59.9 g/m 2 , p = 0.666).

Duodenal and jejunal Btnl2 -KO γδ IELs also showed a trend towards higher diversity in TCR γ chain compared to WT γδ IELs but the difference was marginal when contrasted to their ileal counterparts ( p = 0.0616 and 0.2429, respectively for Shannon diversity when sampling 3500 γ chains, Fig. 5b ).

The baseline expression of miR-3168 ( p = 0.0456, OR = 1.03, 95% CI: 1.00–1.06) and miR-4718 ( p = 0.0388, OR = 1.56, 95% CI: 1.03–2.46) were associated with an increased risk of nephrotoxicity, whereas miR-6125 showed a trend ( p = 0.0618, OR = 1.73, 95% CI: 0.98–3.29).

For example, the Diet dimension score was slightly lower in the higher education group compared to the lower education group (21.73 vs 22.94, P = 0.116), while the Anger and Stress dimension showed a trend toward higher scores in the higher education group (11.88 vs 10.86, P = 0.062).

The degree of mitral regurgitation showed a trend toward being higher in group A (p = 0.062). cMRI was performed in only 23% (312) of all patients and significantly more frequently in group A than in group B patients (p<0.001).